Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial
表达SARS-CoV-2刺突蛋白的灭活重组新城疫病毒疫苗的安全性和免疫原性：一项随机、对照的II期试验
期刊:
影响因子:
doi:10.1016/j.vaccine.2024.126542
Thiem, Vu Dinh; Anh, Dang Duc; Ha, Vu Hai; Van Thom, Nguyen; Thang, Tran Cong; Mateus, Jose; Carreño, Juan Manuel; Raghunandan, Rama; Huong, Nguyen Mai; Mercer, Laina D; Flores, Jorge; Escarrega, E Alexandar; Raskin, Ariel; Thai, Duong Huu; Van Be, Le; Sette, Alessandro; Innis, Bruce L; Krammer, Florian; Weiskopf, Daniela
